MRTX849

Triple meeting – Mirati avoids the worst-case scenario
EP Vantage
Tue, 10/29/19 - 10:34 am
Mirati Therapeutics
MRTX849
lung cancer
colorectal cancer
Mirati sets date for closely watched clinical KRAS readout
Fierce Biotech
Fri, 10/18/19 - 10:12 am
Mirati Therapeutics
KRAS
MRTX849
Amgen
cancer
4 Biotech Stocks With Big Catalysts in September
Motley Fool
Thu, 09/5/19 - 10:14 pm
Amgen
AMG 510
Mirati Therapeutics
MRTX849
Eli Lilly
LOXO-292
Blueprint Me
Pralsetinibdicines
Here's Why Mirati Therapeutics Is Surging Today
Motley Fool
Thu, 05/16/19 - 06:42 pm
Mirati Therapeutics
Amgen
KRAS inhibitors
MRTX849
AMG 510